Nyxoah SA revenue

Nyxoah SA's revenue was $11.3m in fiscal 2025, up 131.6% on the year before. Since fiscal 2020 ($78,731) it has grown at a compound 170.2% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nyxoah SA: revenue history, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	0	1	3	5	5	11
Growth on the year before	—	+>999%	+222.3%	+44.8%	+4.0%	+131.6%
Gross profit	0	1	2	3	3	7
Gross margin	56.5%	64.4%	62.7%	61.9%	65.7%	63.1%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Nyxoah SA	$11.3m	131.6%	—
Inspiremd, Inc.	$10.8m	53.4%	26.6%
Solana Co	$12.1m	3992.2%	142.6%
Nano-x Imaging Ltd.	$13.0m	15.4%	—
Work Medical Technology Group LTD	$9.8m	-14.4%	—
Neuroone Medical Technologies Corp	$9.5m	42.8%	94.9%

Compare with peers

Head to head: NSPR vs NYXH HSDT vs NYXH NNOX vs NYXH

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Nyxoah SA's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nyxoah SA.